Notification of Issue of Securities

30 September 2021
Issue of ordinary shares
This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited (“FPH”) under one or more of FPH’s employee share plans.
This notice is given in reliance on a waiver from NZX Listing Rule 3.13.1 granted by NZX on 6 August 2019 that allows FPH, subject to certain conditions, to disclose the issue of FPH shares under FPH’s employee share plans within 10 business days of issue.
Section 1: issuer information
Name of issuer Fisher & Paykel Healthcare Corporation Limited
NZX ticker code FPH
Class of Financial Product Ordinary shares
ISIN NZFAPE0001S2
Section 2: capital change details
Number of issuances to which this notice relates Nine
Number issued (1) 20,982
(2) 16,404
(3) 11,323
(4) 16,049
(5) 3,568
(6) 10,196
(7) 2,840
(8) 2,643
(9) 13,027
Total issued: 97,032 shares
Nominal value (if any) Not applicable
Issue price (1) NZD0.00 (11,352 shares); NZD14.91 (9,630 shares)
(2) NZD0.00 (4,227 shares); NZD11.81 (3,002 shares); NZD14.91 (9,175 shares)
(3) NZD0.00 (7,133 shares); NZD14.91 (4,190 shares)
(4) NZD0.00 (10,199 shares); NZD14.91 (5,850 shares)
(5) NZD0.00 (840 shares); NZD14.91 (2,728 shares)
(6) NZD0.00 (1,234 shares); NZD11.81 (6,868 shares); NZD14.91 (2,094 shares)
(7) NZD0.00 (1,055 shares); NZD14.91 (1,785 shares)
(8) NZD0.00 (995 shares); NZD14.91 (1,648 shares)
(9) NZD0.00 (6,723 shares); NZD11.81 (1,058 shares); NZD14.91 (5,246 shares)
Nature of the payment Not applicable
Amount paid up (if not in full) In full
Percentage of total class of Financial Products issued (1) 0.00364%
(2) 0.00284%
(3) 0.00196%
(4) 0.00278%
(5) 0.00062%
(6) 0.00177%
(7) 0.00049%
(8) 0.00046%
(9) 0.00226%
For an issue of Convertible Financial Products or Options, the principal terms of Conversion Not applicable
Reason for issue (1) Exercise of 11,352 PSRs under the Performance Share Rights Plan and issue of 11,352 ordinary shares; cancellation of 6,197 options and issue of 3,238 ordinary shares; exercise of 6,392 options under the FPH Share Option Plan and issue of 6,392 ordinary shares.
(2) Exercise of 4,227 PSRs under the Performance Share Rights plan and issue of 4,227 ordinary shares; cancellation of 4,741 options and issue of 3,002 ordinary shares; cancellation of 17,087 options and issue of 9,175 ordinary shares.
(3) Exercise of 7,133 PSRs under the Performance Share Rights Plan and issue of 7,133 ordinary shares; cancellation of 6,049 options and issue of 3,259 ordinary shares; exercise of 931 options under the FPH Share Option Plan and issue of 931 ordinary shares.
(4) Exercise of 10,199 PSRs under the Performance Share Rights Plan and issue of 10,199 ordinary shares; cancellation of 10,828 options and issue of 5,850 ordinary shares.
(5) Exercise of 840 PSRs under the Performance Share Rights Plan and issue of 840 ordinary shares; cancellation of 3,915 options and issue of 2,124 ordinary shares; exercise of 604 options under the FPH Share Option Plan and issue of 604 ordinary shares.
(6) Exercise of 1,234 PSRs under the Performance Share Rights Plan and issue of 1,234 ordinary shares; cancellation of 10,662 options and issue of 6,868 ordinary shares; cancellation of 3,812 options and issue of 2,094 ordinary shares.
(7) Exercise of 1,055 PSRs under the Performance Share Rights Plan and issue of 1,055 ordinary shares; cancellation of 3,261 options and issue of 1,785 ordinary shares.
(8) Exercise of 995 PSRs under the Performance Share Rights Plan and issue of 995 ordinary shares; cancellation of 3,074 options and issue of 1,648 ordinary shares.
(9) Exercise of 6,723 PSRs under the Performance Share Rights Plan and issue of 6,723 ordinary shares; cancellation of 1,673 options and issue of 1,058 ordinary shares; cancellation of 9,919 options and issue of 5,246 ordinary shares.
All cancellations are under the FPH Share Option Plan Cancellation Facility
Total number of Financial Products of the Class after the issue (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue. (1) Total number (excluding Treasury Stock): 576,917,978.
Treasury stock: 137,282
(2) Total number (excluding Treasury Stock): 576,934,382.
Treasury stock: 137,282
(3) Total number (excluding Treasury Stock): 576,945,705.
Treasury stock: 137,282
(4) Total number (excluding Treasury Stock): 576,961,754.
Treasury stock: 137,282
(5) Total number (excluding Treasury Stock): 576,965,322.
Treasury stock: 137,282
(6) Total number (excluding Treasury Stock): 576,975,518.
Treasury stock: 137,282
(7) Total number (excluding Treasury Stock): 576,978,358.
Treasury stock: 137,282
(8) Total number (excluding Treasury Stock): 576,981,001.
Treasury stock: 137,282
(9) Total number (excluding Treasury Stock): 576,994,028.
Treasury stock: 137,282
Total number of ordinary shares on issue as at the date of this notice after the issues disclosed in this notice (excluding Treasury Stock): 576,994,028.
Treasury stock as at the date of this notice: 137,282.
Total number of ordinary shares on issue as at the date of this notice after the issues disclosed in this notice (including Treasury Stock): 577,131,310.
In the case of an acquisition of shares, whether those shares are to be held as treasury stock Not applicable
Specific authority for the issue Directors’ resolution, Listing Rule 4.6
Terms or details of the issue The ordinary shares issued rank pari passu with the existing ordinary shares
Date of issue (1) 20 September 2021
(2) 21 September 2021
(3) 22 September 2021
(4) 23 September 2021
(5) 24 September 2021
(6) 27 September 2021
(7) 28 September 2021
(8) 29 September 2021
(9) 30 September 2021
Section 3: authority for this announcement
Name of person authorised to make this announcement Marcus Driller
Contact phone number +64 9 574 0110
Contact email address [email protected]
Date of release via MAP 30 September 2021

---

Announcement PDF